Revelation Biosciences, Inc. Common Stock

Go to Revelation Biosciences, Inc. Common Stock Website

$2.56

0.02 (0.79%)
Live
Previous Close

$2.54

Day Range

$2.54 - $2.7

Previous Day Range

$2.42 - $2.5967

Market Cap

$3.7 million USD

Day Vol.

23176

Previous Day Vol.

104249

Currency

USD

Primary Exchange

Nasdaq

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini....


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Do elections impact the price of penny stocks or not? The post How an Election Impacts Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Related tickers: AGFY, EPOW, REVB.

Read Full Article

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. BIOLASE, Inc. (NASDAQ: BIOL) On Jan. 29, Biolase reported full-year 2023 interim revenue of $48.9 million to $49.2 million, up 1% year-over-year compared to the consensus of $49.21 million. The company’s stock fell around 43% over the past five days ...

Related tickers: GILD, BIOL, ZLAB, REVB, CNSP.

Read Full Article
Trending Tickers

Please sign in to view